Seven Bridges Stock
Biomedical Data Science Company
Sign up today and learn more about Seven Bridges Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Seven Bridges Stock
Seven Bridges is the industry-leading infrastructure and data analytics company accelerating precision medicine by enabling the understanding of biomedical data. Our platform, services, and support expertise are driving discovery and drug development at the world’s leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaborations with the largest genomics projects, we connect the world’s biomedical information to enable the most efficient analysis at scale. Named one of the world's smartest companies by MIT Technology Review, and a three-time Bio-IT World Best of Show winner, Seven Bridges has offices in Belgrade, Boston, Istanbul, and San Francisco.
Investors
First Star Ventures
Kryssen Capital
Funding History
| September 2014 | $3.0M |
|---|---|
| February 2016 | $45.0M |
| April 2018 | $50.0M |
| April 2021 | $15.0M |
Management
Chief Executive Officer
William Moss
Chief Financial Officer
Robert Shay
Chief Technology Officer
David Ramos
Press
genomeweb - Sep, 9 2021
Seven Bridges, Scripps Research Win $7.5M Contract to Develop NIAID Data Ecosystembit - Aug, 26 2021
RTI International Makes Investment in Seven Bridges Genomicsaithority - Mar, 4 2021
Seven Bridges Announces Strategic Advisory Board Appointmentspharmiweb - Sep, 23 2020
Seven Bridges Advances Workflow Automation Capabilities to Make Complex Multi-Omic Analysis More Accessible to Broader Mix of Userszpr - Dec, 18 2019
Seven Bridges Announces Mike Bigda as Chief Operating OfficerEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
